ResMed Net Income 2006-2018 | RMD

ResMed annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • ResMed net income for the quarter ending September 30, 2018 was $0.106B, a 22.77% increase year-over-year.
  • ResMed net income for the twelve months ending September 30, 2018 was $0.335B, a 4.85% decline year-over-year.
  • ResMed annual net income for 2018 was $0.316B, a 7.8% decline from 2017.
  • ResMed annual net income for 2017 was $0.342B, a 2.87% decline from 2016.
  • ResMed annual net income for 2016 was $0.352B, a 0.14% decline from 2015.
ResMed Annual Net Income
(Millions of US $)
2018 $316
2017 $342
2016 $352
2015 $353
2014 $345
2013 $307
2012 $255
2011 $227
2010 $190
2009 $146
2008 $110
2007 $66
2006 $88
2005 $65
ResMed Quarterly Net Income
(Millions of US $)
Q1 2018 $106
Q4 2018 $110
Q3 2018 $110
Q2 2017 $10
Q1 2017 $86
Q4 2017 $102
Q3 2017 $88
Q2 2016 $77
Q1 2016 $76
Q4 2016 $83
Q3 2016 $91
Q2 2015 $96
Q1 2015 $83
Q4 2015 $87
Q3 2015 $91
Q2 2014 $91
Q1 2014 $83
Q4 2014 $88
Q3 2014 $90
Q2 2013 $87
Q1 2013 $81
Q4 2013 $73
Q3 2013 $85
Q2 2012 $78
Q1 2012 $71
Q4 2012 $77
Q3 2012 $65
Q2 2011 $63
Q1 2011 $51
Q4 2011 $58
Q3 2011 $53
Q2 2010 $58
Q1 2010 $57
Q4 2010 $53
Q3 2010 $49
Q2 2009 $46
Q1 2009 $42
Q4 2009 $45
Q3 2009 $39
Q2 2008 $34
Q1 2008 $28
Q4 2008 $30
Q3 2008 $30
Q2 2007 $27
Q1 2007 $24
Q4 2007 $28
Q3 2007 $-15
Q2 2006 $29
Q1 2006 $25
Q4 2006 $23
Q3 2006 $26
Q2 2005 $22
Q1 2005 $16
Q4 2005 $16
Q3 2005 $18
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.846B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00